In April 2023, the healthcare industry reported 62 deals worth 22.7 bn GlobalData - Express Pharma

Slightly above 67% of Prometheus Biosciences' investor base is looking to short. The analysis of current outlook of investing in Prometheus Biosciences suggests that many traders are alarmed regarding Prometheus Biosciences' prospects. Prometheus Biosciences' investing sentiment can be driven by a variety of factors including economic data, Prometheus Biosciences' earnings reports, geopolitical events, and overall market trends.
  
In April 2023, the healthcare industry reported 62 deals worth 22.7 bn GlobalData Express Pharma

Read at news.google.com
Google News at Macroaxis
  

Prometheus Biosciences Fundamental Analysis

We analyze Prometheus Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Prometheus Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Prometheus Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

Prometheus Biosciences is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

Prometheus Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Prometheus Biosciences stock to make a market-neutral strategy. Peer analysis of Prometheus Biosciences could also be used in its relative valuation, which is a method of valuing Prometheus Biosciences by comparing valuation metrics with similar companies.

Peers

Prometheus Biosciences Related Equities

PLRXPliant Therapeutics   4.49   
0%
79.0%
VKTXViking Therapeutics   3.06   
0%
54.0%
ACLXArcellx   1.88   
0%
33.0%
ETNB89bio   1.19   
0%
21.0%
IMVTImmunovant   0.85   
0%
15.0%
AKROAkero Therapeutics   0.40   
0%
7.0%
KRYSKrystal Biotech   0.00   
0%
0%
AMLXAmylyx Pharmaceuticals   0.94   
16.0%
0%
BPMCBlueprint Medicines   1.07   
18.0%
0%
APLSApellis Pharmaceuticals   1.25   
22.0%
0%
TERNTerns Pharmaceuticals   1.86   
32.0%
0%
ROIVRoivant Sciences   2.08   
36.0%
0%
STOKStoke Therapeutics   3.39   
59.0%
0%
DAWNDay One   4.36   
77.0%
0%
MDGLMadrigal Pharmaceuticals   5.66   
100.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in Prometheus Stock

If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years